Janux Therapeutics Inc (JANX) returns
Janux Therapeutics returns over 5 years
$1,000 invested in Janux Therapeutics five years ago was worth $717.45 at the close on October 30, 2026, with dividends reinvested: an average return of -6.4% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +1.1% | — | $1,011 | -0.9% |
| 3 months | +12.1% | — | $1,121 | +2.1% |
| Year to date | +26.6% | — | $1,266 | +11.7% |
| 1 year | -38.7% | — | $612.77 | +12.4% |
| 3 years | +185.0% | +41.8% | $2,850 | +88.5% |
| 5 years | -28.3% | -6.4% | $717.45 | +76.0% |
Janux Therapeutics return by calendar year
| Year | JANX | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +26.6% | +11.7% | +14.9% |
| 2025 | -74.2% | +17.7% | -91.9% |
| 2024 | +399.0% | +24.9% | +374.1% |
| 2023 | -18.5% | +26.2% | -44.7% |
| 2022 | -33.2% | -18.2% | -15.1% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: JANX financials
No forecast, no recommendation. This page describes Janux Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.